Drugs / Mycobacterium w immunotherapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00810849 Comparator | Dec 2008 → Feb 2014 | pericardial tuberculosis | University of Cape Town | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mycobacterium w immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00810849 ↗ |
| Known as | Mycobacterium w | “vaccination with the Mycobacterium w injection is also proposed as a possible way of reducing the damage caused by the tuberculosis infection of the heart.” NCT00810849 ↗ |
| Modality | Vaccine | “5 doses of 0.1 ml of the vaccine intradermally” NCT00810849 ↗ |